20th Anniversary Conference: Stem Cells, Cell Therapies, and Bioengineering in Lung Biology and Diseases

  07 Jul 2025 - 10 Jul 2025

   Burlington, VT, United States

conference-img

20th Anniversary Conference: Stem Cells, Cell Therapies, and Bioengineering in Lung Biology and Diseases

07 Jul 2025

 - 

10 Jul 2025

Burlington, VT, United States



This biennial conference draws top researchers in the field and their trainees from around the world.

The purpose of the conference is to discuss recent research, explore opportunities for new collaborations, and identify the most important needs and priorities for future programs in stem cell, cell therapy, and bioengineering approaches to explore lung biology and/or prevent and treat lung diseases. Optional Pre-conference workshop: Hands-on Training in State-of-the-Art Methods in Stem Cells, Cell Therapies, and Bioengineering - July 7, 2025.

International Conference on Medical and Health Sciences

On: 25 May 2026

-

26 May 2026


International Conference on Sexual and Reproductive Health

On: 25 May 2026

-

25 May 2026


International Conference on Cardiology and Cardiovascular Medicine

On: 25 May 2026

-

25 May 2026


International Conference on Cardiology and Cardiovascular Medicine

On: 25 May 2026

-

25 May 2026


International Conference on Cardiology and Cardiovascular Medicine

On: 25 May 2026

-

25 May 2026


International Conference on Medical and Health Sciences

On: 25 May 2026

-

26 May 2026


International Conference on Sexual and Reproductive Health

On: 25 May 2026

-

25 May 2026


International Conference on Cardiology and Cardiovascular Medicine

On: 25 May 2026

-

25 May 2026


International Conference on Cardiology and Cardiovascular Medicine

On: 25 May 2026

-

25 May 2026


International Conference on Cardiology and Cardiovascular Medicine

On: 25 May 2026

-

25 May 2026



Whats more on Hidoc Dr.


Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Non-Factor Therapies in Hemophilia: Cutting-Edge Approaches to Individualize Care

2.

FDA approves Blenrep for relapsed or refractory multiple myeloma

3.

X-ray and radar technology combined to reduce cancer screening risks

4.

Extended Maintenance with Imatinib Enhances Disease-Free Survival in High-Risk GIST.

5.

Researchers discuss HER2-low and HER2-zero in breast cancer

Recommended News For You

Conferences That Might Interest You

Recommended Articles For You

Boost Your Knowledge With These Quizzes





© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot